FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry, namely, to a local haemostatic antibacterial agent for suppressing massive bleeding. Local haemostatic antibacterial agent for suppressing massive bleeding, constituting a macromolecular complex of a chitosan salt and an antibacterial agent, wherein the chitosan salt is bound to the antibacterial agent by intermolecular hydrogen bonds, and 2,3-bis-(hydroxymethyl)-quinoxalin-1,4-di-N-oxide with a mass fraction from 0.5% to 20% acts as an antibacterial agent, the chitosan salt is selected from chitosan formate, acetate, citrate, glycolate, or lactate.
EFFECT: above agent is effective in suppressing massive bleeding, exhibits high antibacterial activity.
3 cl, 3 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
LOCAL HEMOSTATIC AGENT | 2013 |
|
RU2519220C1 |
NEW COMPOSITIONS OF 2,3-BIS-(HYDROXYMETHYL)QUINOXALINE 1,4-DI-N-OXIDE FOR TOPICAL APPLICATION | 2021 |
|
RU2791248C2 |
COMPOSITION FOR WOUND TREATMENT AND PRODUCTS ON ITS BASIS | 2011 |
|
RU2467767C1 |
MEDICINAL MATERIAL AND PRODUCTS BASED UPON THIS MATERIAL | 2002 |
|
RU2249467C2 |
ANTISEPTIC COMPOSITION "CHLORDIX" | 2007 |
|
RU2351365C2 |
HAEMOSTATIC AGENT BASED ON CHITOSAN SUCCINATE AND CALENDULA EXTRACT | 2019 |
|
RU2694372C1 |
HEMOSTATIC AND ANTISEPTIC AGENT | 1997 |
|
RU2132678C1 |
COMPLEX COMPOSITION OF CHITOSAN SUCCINATE AND CHLORHEXIDINE POSSESSING ANTIBACTERIAL AND WOUND HEALING EFFECT | 2011 |
|
RU2471477C1 |
LOCAL HEMOSTATIC AGENT | 2012 |
|
RU2522206C1 |
BIOLOGICALLY ACTIVE FIBER SHEETING | 2010 |
|
RU2443823C1 |
Authors
Dates
2022-07-12—Published
2021-06-24—Filed